⚠ BETA β€” all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026

NSE

Ajooni Biotech LimitedAJOONI

Ajooni Biotech Limited is an Indian biotechnology company focused on developing and commercializing innovative healthcare solutions.

Key productsBiopharmaceuticals, diagnostics
GeographyIndia
CompetitorsBiocon Ltd., Dr. Reddy's Laboratories

AI-generated overview β€” verify before relying on it.

Net institutional flow

No institutional deals

Institutional buyers

0 in / 0 out

High-impact filings

0 Β· tilt Neutral

Next corporate action

β€”

Competitive landscape β€” the read

vs most-traded names Β· 6M
Institutional money is backing ATALREAL hardest (+β‚Ή5.2 Cr net). AJOONI ranks #4 of 7 on flow (net buying +β‚Ή0 Cr).
#CompanyInst. flow β‚ΉCrDealsHi-impactFiling mom.BuzzNews
1ATALREAL+β‚Ή5.2 Cr162β€”β€”β€”β€”
2QUADFUTURE+β‚Ή0.1 Cr148β€”β€”β€”β€”
3MOBIKWIK+β‚Ή0.1 Cr83β€”β€”β€”β€”
4AJOONIThisβ€”β€”β€”β€”β€”β€”
5MTNL+β‚Ή0 Cr2β€”β€”β€”β€”
6GATECH+β‚Ή0 Cr8β€”β€”β€”β€”
7IRMENERGYβˆ’β‚Ή2.2 Cr328β€”β€”β€”β€”

Ranked by net institutional flow (buys βˆ’ sells, β‚ΉCr). Filing momentum = bullish βˆ’ bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

SWOT

Strengths

  • β€’ Developing innovative vaccines for infectious diseases
  • β€’ Strong pipeline of biopharmaceutical products
  • β€’ Growing presence in the Indian pharmaceutical market

Weaknesses

  • β€’ Dependence on a limited number of products and revenue streams
  • β€’ High research and development expenses
  • β€’ Competition from established players like Biocon Ltd.

Opportunities

  • β€’ Increasing demand for vaccines and biopharmaceuticals due to growing healthcare needs in India
  • β€’ Partnerships with international companies to expand product portfolio
  • β€’ Growing focus on personalized medicine and genomics

Threats

  • β€’ Regulatory challenges and changes in government policies affecting the pharmaceutical industry
  • β€’ Competition from generic drugs and biosimilars
  • β€’ Global health crises and pandemics impacting demand for biopharmaceuticals

AI-generated from our data β€” verify before relying on it.

Filings that matter

No scored filings for AJOONI yet.

Bulk & block deals

No bulk/block deals for AJOONI in this window.

News & chatter on AJOONI

RSS News

0

No recent news.

Google News RSS β€” links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.